Literature DB >> 16985799

Thyroid autoantibodies, telomerase activity, vascular endothelial growth factor, and bone scanning.

A van Ophoven, B Patel, M K Rauch, A Belldegrun.   

Abstract

Entities:  

Year:  1999        PMID： 16985799      PMCID： PMC1477536     

Source DB:  PubMed          Journal:  Rev Urol        ISSN： 1523-6161


× No keyword cloud information.
  17 in total

1.  Staging of renal cell carcinoma: cost-effectiveness of routine preoperative bone scans.

Authors:  R J Campbell; S B Broaddus; G W Leadbetter
Journal:  Urology       Date:  1985-03       Impact factor: 2.649

2.  Staging renal carcinoma. What is sufficient?

Authors:  M A Benson; J R Haaga; M I Resnick
Journal:  Arch Surg       Date:  1989-01

3.  Telomerase activity in patients with transitional cell carcinoma: a preliminary study.

Authors:  M A Rahat; N Lahat; H Gazawi; M B Resnick; Y Sova; G Ben-Ari; M Cohen; A Stein
Journal:  Cancer       Date:  1999-02-15       Impact factor: 6.860

4.  Expression of vascular endothelial growth factor in patients with testicular germ cell tumors as an indicator of metastatic disease.

Authors:  S Fukuda; T Shirahama; Y Imazono; T Tsushima; H Ohmori; T Kayajima; S Take; K Nishiyama; S Yonezawa; S Akiba; S Akiyama; Y Ohi
Journal:  Cancer       Date:  1999-03-15       Impact factor: 6.860

5.  Association of radionuclide bone scan and serum alkaline phosphatase in patients with metastatic renal cell carcinoma.

Authors:  E Seaman; E T Goluboff; S Ross; I S Sawczuk
Journal:  Urology       Date:  1996-11       Impact factor: 2.649

6.  Primary hypothyroidism associated with interleukin-2 and interferon alpha-2 therapy of melanoma and renal carcinoma.

Authors:  S Scalzo; A Gengaro; G Boccoli; R Masciulli; G Giannella; G Salvo; P Marolla; P Carlini; G Massimini; E E Holdener
Journal:  Eur J Cancer       Date:  1990       Impact factor: 9.162

7.  Detection of human telomerase reverse transcriptase messenger RNA in voided urine samples as a useful diagnostic tool for bladder cancer.

Authors:  H Ito; S Kyo; T Kanaya; M Takakura; K Koshida; M Namiki; M Inoue
Journal:  Clin Cancer Res       Date:  1998-11       Impact factor: 12.531

8.  Value of serum alkaline phosphatase and radionuclide bone scans in patients with renal cell carcinoma.

Authors:  I Atlas; D Kwan; N Stone
Journal:  Urology       Date:  1991-09       Impact factor: 2.649

9.  Is there a diagnostic role for bone scanning of patients with a high pretest probability for metastatic renal cell carcinoma?

Authors:  A Staudenherz; B Steiner; S Puig; F Kainberger; T Leitha
Journal:  Cancer       Date:  1999-01-01       Impact factor: 6.860

10.  Telomerase activity in human bladder cancer.

Authors:  Y Lin; H Miyamoto; K Fujinami; H Uemura; M Hosaka; Y Iwasaki; Y Kubota
Journal:  Clin Cancer Res       Date:  1996-06       Impact factor: 12.531
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.